NAD+: Safety, Side Effects & Regulation
This guide collects everything we’ve researched on NAD+ in the area of safety, side effects & regulation. Each question below contrasts what AI assistants report with what the peer-reviewed literature in our research corpus actually shows.
Questions in this guide
- What are the long-term safety profiles of high-dose NAD+ supplementation, including potential impacts on liver function, immune modulation, and cancer risk?
- Are there any documented cases of NAD+ supplementation causing adverse effects such as flushing, gastrointestinal distress, or altered liver enzyme levels in clinical studies?
- Is there evidence that NAD+ supplementation can exacerbate pre-existing conditions such as cancer or autoimmune disorders, particularly in high-dose regimens?
- Are there any known drug interactions between NAD+ precursors and medications such as statins, anticoagulants, or chemotherapy agents?
Continue your journey
What are the known adverse effects of exogenous kisspeptin administration in humans, and how do they compare to gonadotropin therapy?How does NAD+ supplementation support tissue regeneration in injured neurons and muscle cells, and what role does it play in mitochondrial recovery after metabolic stress?How do the efficacy and pharmacokinetics of NMN, nicotinamide riboside, and nicotinamide compare in boosting intracellular NAD+ levels across different tissues?What is the therapeutic window for NAD+ precursors, and how do dose-dependent effects vary between acute supplementation and long-term use?NAD+: Brain & Nervous SystemNAD+: Mechanisms & How It Works